TA
GNMK

Teachers Advisors’s GenMark Diagnostics, Inc GNMK Stock Holding History

Teachers Advisors’s Portfolio GNMK Stock Details GNMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$1.1M Buy
154,802
+30,659
+25% +$202K ﹤0.01% 2251
2018
Q4 		$603K Sell
124,143
-5,078
-4% -$26.4K ﹤0.01% 2431
2018
Q3 		$950K Buy
129,221
+1,022
+0.8% +$7.5K ﹤0.01% 2339
2018
Q2 		$818K Buy
128,199
+3,424
+3% +$22.6K ﹤0.01% 2433
2018
Q1 		$679K Sell
124,775
-470
-0.4% -$2.34K ﹤0.01% 2391
2017
Q4 		$522K Buy
125,245
+12,713
+11% +$76.5K ﹤0.01% 2545
2017
Q3 		$1.08M Buy
112,532
+3,757
+3% +$39K ﹤0.01% 2186
2017
Q2 		$1.29M Sell
108,775
-2,309
-2% -$29.5K ﹤0.01% 2084
2017
Q1 		$1.42M Buy
111,084
+12,864
+13% +$155K ﹤0.01% 1962
2016
Q4 		$1.2M Buy
98,220
+5,652
+6% +$67.1K ﹤0.01% 2079
2016
Q3 		$1.09M Buy
92,568
+194
+0.2% +$1.87K ﹤0.01% 2027
2016
Q2 		$804K Hold
92,374
– – ﹤0.01% 2148
2016
Q1 		$487K Hold
92,374
– – ﹤0.01% 2359
2015
Q4 		$717K Buy
92,374
+19,119
+26% +$147K ﹤0.01% 2200
2015
Q3 		$577K Buy
73,255
+1,269
+2% +$11.7K ﹤0.01% 2303
2015
Q2 		$652K Buy
71,986
+10,511
+17% +$106K ﹤0.01% 2362
2015
Q1 		$798K Hold
61,475
– – ﹤0.01% 2176
2014
Q4 		$837K Hold
61,475
– – ﹤0.01% 2136
2014
Q3 		$551K Hold
61,475
– – ﹤0.01% 2348
2014
Q2 		$832K Buy
61,475
+2,094
+4% +$21.8K ﹤0.01% 2141
2014
Q1 		$590K Buy
59,381
+8,915
+18% +$111K ﹤0.01% 2312
2013
Q4 		$672K Buy
50,466
+9,160
+22% +$111K ﹤0.01% 2218
2013
Q3 		$502K Buy
41,306
+2,485
+6% +$26.6K ﹤0.01% 2314
2013
Q2 		$401K Buy
+38,821
New +$535K ﹤0.01% 2358

Other funds holding GNMK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Teachers Advisors's GNMK Position: Q1 2019 in Review

Teachers Advisors increased its GenMark Diagnostics, Inc (GNMK) stake by 25% in Q1 2019, buying an estimated $202K and bringing the position to 154,802 shares worth $1.1M. The position accounts for ﹤0.01% of the portfolio, ranked #2251.

Teachers Advisors first reported a position in GNMK in Q2 2013 and has held it in 24 quarters since. The position peaked at $1.42M in Q1 2017. 106 funds tracked by Wall St. Rank hold GNMK as of Q1 2019.

  • Teachers Advisors held 154,802 shares of GenMark Diagnostics, Inc worth $1.1M as of Q1 2019.
  • Teachers Advisors bought 30,659 GenMark Diagnostics, Inc shares in Q1 2019, an estimated $202K.
  • GenMark Diagnostics, Inc made up ﹤0.01% of Teachers Advisors's portfolio in Q1 2019, its #2251 holding.
  • Teachers Advisors first reported a position in GenMark Diagnostics, Inc in Q2 2013 and has held it in 24 quarters since.
  • Teachers Advisors's GenMark Diagnostics, Inc position peaked at $1.42M in Q1 2017.
  • 106 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q1 2019.

Based on Teachers Advisors's 13F filing for Q1 2019, filed 14 May 2019.